Browsing Tag
oligonucleotides
2 posts
Sai Life Sciences (NSE: SAILIFE) Q2 FY26 profit doubles on CRDMO demand, high-value tech expansion
Sai Life Sciences profit doubled in Q2 FY26, driven by peptide, ADC, and oligo expansion. See how the CRDMO firm is gaining margin and investor traction.
Suven Pharmaceuticals reports 12% revenue growth for Q2 with strong outlook
Suven Pharmaceuticals Ltd. (BSE: 530239, NSE: SUVENPHARM), a technology-focused Contract Development and Manufacturing Organization (CDMO) headquartered in Hyderabad,…